Compare GRANULES INDIA with STRIDES PHARMA SCIENCE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GRANULES INDIA vs STRIDES PHARMA SCIENCE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GRANULES INDIA STRIDES PHARMA SCIENCE GRANULES INDIA/
STRIDES PHARMA SCIENCE
 
P/E (TTM) x 15.3 -16.2 - View Chart
P/BV x 3.4 1.2 280.6% View Chart
Dividend Yield % 0.5 0.7 76.1%  

Financials

 GRANULES INDIA   STRIDES PHARMA SCIENCE
EQUITY SHARE DATA
    GRANULES INDIA
Mar-21
STRIDES PHARMA SCIENCE
Mar-21
GRANULES INDIA/
STRIDES PHARMA SCIENCE
5-Yr Chart
Click to enlarge
High Rs4381,000 43.8%   
Low Rs138304 45.4%   
Sales per share (Unadj.) Rs130.7369.7 35.4%  
Earnings per share (Unadj.) Rs22.239.6 56.0%  
Cash flow per share (Unadj.) Rs28.362.6 45.2%  
Dividends per share (Unadj.) Rs1.502.50 60.0%  
Avg Dividend yield %0.50.4 135.8%  
Book value per share (Unadj.) Rs86.8309.1 28.1%  
Shares outstanding (eoy) m247.6789.68 276.2%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.21.8 125.0%   
Avg P/E ratio x13.016.4 79.0%  
P/CF ratio (eoy) x10.210.4 97.8%  
Price / Book Value ratio x3.32.1 157.2%  
Dividend payout %6.86.3 107.2%   
Avg Mkt Cap Rs m71,33758,465 122.0%   
No. of employees `000NANA-   
Total wages/salary Rs m3,2435,501 58.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m32,37533,159 97.6%  
Other income Rs m269734 36.6%   
Total revenues Rs m32,64433,893 96.3%   
Gross profit Rs m8,5526,702 127.6%  
Depreciation Rs m1,5152,063 73.4%   
Interest Rs m2631,501 17.5%   
Profit before tax Rs m7,0443,872 181.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,549317 489.4%   
Profit after tax Rs m5,4953,555 154.5%  
Gross profit margin %26.420.2 130.7%  
Effective tax rate %22.08.2 269.0%   
Net profit margin %17.010.7 158.3%  
BALANCE SHEET DATA
Current assets Rs m19,97028,172 70.9%   
Current liabilities Rs m11,73127,383 42.8%   
Net working cap to sales %25.42.4 1,069.7%  
Current ratio x1.71.0 165.5%  
Inventory Days Days16165 9.9%  
Debtors Days Days863122 708.3%  
Net fixed assets Rs m17,15739,996 42.9%   
Share capital Rs m248897 27.6%   
"Free" reserves Rs m21,26226,823 79.3%   
Net worth Rs m21,51027,719 77.6%   
Long term debt Rs m3,4118,826 38.7%   
Total assets Rs m37,12768,168 54.5%  
Interest coverage x27.83.6 776.4%   
Debt to equity ratio x0.20.3 49.8%  
Sales to assets ratio x0.90.5 179.3%   
Return on assets %15.57.4 209.1%  
Return on equity %25.512.8 199.2%  
Return on capital %29.314.7 199.4%  
Exports to sales %81.951.1 160.4%   
Imports to sales %26.80-   
Exports (fob) Rs m26,52816,941 156.6%   
Imports (cif) Rs m8,691NA-   
Fx inflow Rs m26,52835,084 75.6%   
Fx outflow Rs m8,691392 2,217.6%   
Net fx Rs m17,83734,692 51.4%   
CASH FLOW
From Operations Rs m4,3254,814 89.8%  
From Investments Rs m-2,771-5,208 53.2%  
From Financial Activity Rs m-2,993-158 1,894.9%  
Net Cashflow Rs m-1,441-564 255.5%  

Share Holding

Indian Promoters % 41.6 29.3 141.9%  
Foreign collaborators % 0.4 0.3 129.6%  
Indian inst/Mut Fund % 25.7 40.9 62.8%  
FIIs % 21.4 19.9 107.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 58.0 70.4 82.4%  
Shareholders   216,385 125,553 172.3%  
Pledged promoter(s) holding % 7.0 38.2 18.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GRANULES INDIA With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

TVS Acquires Largest Swiss E-Bike Company, Canara Bank Quarterly Results, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a weak note yesterday.

Related Views on News

STRIDES PHARMA SCIENCE 2020-21 Annual Report Analysis (Annual Result Update)

Oct 22, 2021 | Updated on Oct 22, 2021

Here's an analysis of the annual report of STRIDES PHARMA SCIENCE for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of STRIDES PHARMA SCIENCE. Also includes updates on the valuation of STRIDES PHARMA SCIENCE.

GRANULES INDIA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of GRANULES INDIA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GRANULES INDIA. Also includes updates on the valuation of GRANULES INDIA.

The Most Oversold Stocks in India. Is it Finally Time to Get in? (Views On News)

Jan 7, 2022

With the help of relative strength index (RSI), we take a look at top stocks that are oversold at current levels.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

More Views on News

Most Popular

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

5 Hidden Tata Group Companies to Add to Your Watchlist(Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

Insiders are Buying into these 6 Stocks Aggressively. More Details here...(Views On News)

Jan 19, 2022

While promoter holding is an important parameter, it should not be the sole reason for buying a stock.

Top Indian Drone Companies to Watch Out for in 2022(Views On News)

Jan 21, 2022

Several companies are adopting drone technology for regular business operations.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GRANULES INDIA SHARE PRICE


Jan 27, 2022 (Close)

TRACK GRANULES INDIA

  • Track your investment in GRANULES INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GRANULES INDIA

GRANULES INDIA 5-YR ANALYSIS

COMPARE GRANULES INDIA WITH

MARKET STATS